Mericanapharma

India Founded: 2019 • Age: 7 yrs
Offers affordable pharmaceutical products and services for global community.

About Mericanapharma

Mericanapharma is a Healthcare company based in India founded in 2019. It offers affordable pharmaceutical products and services for global community. It operates on a B2B and D2C model. Its Indian entity Mericana Pharmaceuticals Private Limited reported revenue of β‚Ή3.65 Cr. Mericanapharma offers products and services including Pharmaceutical Products and Export Services. Its focus areas include Pharmaceuticals, Global Exports, Maternal Health Products and Drug Manufacturing.

Company details

Mericana Pharma focuses on serving the global community by supplying high-quality pharmaceutical products at affordable prices, emphasizing innovation in healthcare. The company operates with a mission to enhance accessibility and includes maternal care aspects in its offerings. Based in India, it exports products worldwide and provides services like global distribution to improve health outcomes, while maintaining a strong online and export presence.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mericanapharma.com
  • Legal Name Mericana Pharmaceuticals Private Limited
  • Date of Incorporation 29 Mar, 2019
  • Jurisdiction Indore, Madhya Pradesh, India
Key Metrics
  • Annual Revenue
    ₹3.65 Cr

    FY 2025 · -43% YoY

  • Net Profit
    ₹4 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹11.6 Lakh

    FY 2025 · 3% margin

Products & Services of Mericanapharma

Mericanapharma offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Export Services.

Pharmaceutical Products
Healthcare

Quality drugs offered at affordable prices for global markets.

Export Services
Distribution

Global export of pharmaceutical items to enhance accessibility.

Board of directors of Mericana Pharmaceuticals Private Limited (Mericanapharma)

Mericana Pharmaceuticals Private Limited is the primary company behind Mericanapharma. The board of Mericana Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Suresh Kshirsagar, appointed in 2019. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Suresh Kshirsagar
DIN 08405853
Director29 Mar 20197 yrs 6 moMericana Pharmaceuticals Private Limited
Madan Kumar Sinha
DIN 08405822
Director29 Mar 20197 yrs 6 moMericana Pharmaceuticals Private Limited
Gaurav Kshirsagar
DIN 08800933
Director24 Sep 20206 yrsMericana Pharmaceuticals Private Limited
Priyesh Kumar Sinha
DIN 08800934
Director24 Sep 20206 yrsMericana Pharmaceuticals Private Limited

Financials of Mericanapharma

Figures of Mericana Pharmaceuticals Private Limited, the primary company behind Mericanapharma, for FY 2025. Revenue was ₹3.65 Cr (-43% year on year). Net profit was ₹4 Lakh (1% margin). EBITDA was ₹11.6 Lakh (3% margin). Revenue has grown at a compounded annual rate of -8% over three years and +3% over five years.

  • ₹3.65 CrRevenue · FY 2025 · -43% YoY
  • ₹4 LakhNet profit · 1% margin
  • ₹11.6 LakhEBITDA · 3% margin
  • ₹1 LakhPaid-up capital
  • -8%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mericana Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Mericanapharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Mericanapharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mericanapharma

Mericanapharma was founded in 2019.

Mericanapharma is headquartered in India.

The primary company behind Mericanapharma, Mericana Pharmaceuticals Private Limited, reported revenue of β‚Ή3.65 Cr for FY 2025, down 43% year on year.

Mericana Pharma focuses on serving the global community by supplying high-quality pharmaceutical products at affordable prices, emphasizing innovation in healthcare. The company operates with a mission to enhance accessibility and includes maternal care aspects in its offerings. Based in India, it exports products worldwide and provides services like global distribution to improve health outcomes, while maintaining a strong online and export presence.

Mericanapharma offers Pharmaceutical Products and Export Services.

Mericanapharma operates through Mericana Pharmaceuticals Private Limited.

The legal entities of Mericanapharma currently have 4 directors, including Suresh Kshirsagar, Gaurav Kshirsagar, Priyesh Kumar Sinha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available